Skip to content

Effect of protein hydrolysate on blood glucose control in women with gestational diabetes.

Effect of protein hydrolysate on blood glucose control in women with gestational diabetes.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23081
Enrollment
50
Registered
2009-06-09
Start date
2009-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women with gestational diabetes mellitus.

Interventions

Women will receive either a protein hydrolysate-containing drink or a control drink containing 8.5 g protein hydrolysate dissolved in water that will be consumed twice daily for in total 15 times (i.e

Sponsors

Erasmus Medical Center Rotterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Gestational age >20 wks and <36 wks; 2. Positive plasma glucose screen or positive 75 g OGTT; 3. Singleton pregnancy; 4. Subject is willing to undergo all protocol related assessments; 5. Subject has read the information provided on the study and given written consent.

Exclusion criteria

Exclusion criteria: 1. 3 plasma glucose levels >9 mmol/L or 1 plasma glucose level >11 mmol/L after which subjects will start insulin treatment; 2. Diagnosed type-1 or type 2 diabetes; 3. Renal insufficiency (GFR 70 IU/L; 5. Anaemia (Hemoglobin level <7.0 mmol/l); 6. Any clinical condition or laboratory test result that in the opinion of the investigators may jeopardise the health status of the participants; 7. Subjects who are enrolled in an another intervention study or have received an intervention within the last 14 days prior to screening.

Design outcomes

Primary

MeasureTime frame
4 -h postprandial Area Under the Curve (AUC) for blood insulin, glucose and C-peptide after protein hydrolysate or control drink followed by breakfast at Day 1.

Secondary

MeasureTime frame
1. 4 -h postprandial AUC for blood insulin, glucose and C-peptide after protein hydrolysate or control drink followed by breakfast at Day 8; 2. Changes from baseline in the mean daily postprandial capillary glucose concentration (3xdaily) during the 7-day protein hydrolysate/control intake period; 3. Changes from baseline in the mean daily capillary glucose AUC (5x daily) during the 7 day protein hydrolysate/control drink intake period; 4. Daily AUC and time above glucose upper limit (>7 mmol/l) for continuous glucose measurements at day 2,3,4.

Contacts

Public ContactWilly Visser

Dr Molewaterplein 60

willy.visser@erasmusmc.nl010-7036614

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)